Blood News and Research

RSS
‘Window for intervention’ to forestall hypertensive cognitive decline

‘Window for intervention’ to forestall hypertensive cognitive decline

BioLineRx reports promising initial results from Phase 2 trial of BL-8040 in AML patients

BioLineRx reports promising initial results from Phase 2 trial of BL-8040 in AML patients

MicroBiome Therapeutics announces completion of $1.3M bridge financing

MicroBiome Therapeutics announces completion of $1.3M bridge financing

Two UTHealth professors elected fellows of American Association for the Advancement of Science

Two UTHealth professors elected fellows of American Association for the Advancement of Science

Better to fat finger a text than to lose a finger due to the cold

Better to fat finger a text than to lose a finger due to the cold

Stem cell technology: an interview with Professor Igor Slukvin, University of Wisconsin-Madison and scientific founder of CDI and Cynata

Stem cell technology: an interview with Professor Igor Slukvin, University of Wisconsin-Madison and scientific founder of CDI and Cynata

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Switching chemotherapy does not improve survival in metastatic breast cancer patients with CTCs

Switching chemotherapy does not improve survival in metastatic breast cancer patients with CTCs

NTU researchers find way to block invasion of Malaria parasite in blood cells

NTU researchers find way to block invasion of Malaria parasite in blood cells

Red state residents enrolling in Obamacare at lower rates

Red state residents enrolling in Obamacare at lower rates

NIH Stroke Trials Network includes UC San Diego Health System as grant recipient

NIH Stroke Trials Network includes UC San Diego Health System as grant recipient

Combination of ramucirumab and docetaxel fails to delay advanced breast cancer progression

Combination of ramucirumab and docetaxel fails to delay advanced breast cancer progression

Researchers gather first direct evidence of how microbubbles cause blood clot's demise

Researchers gather first direct evidence of how microbubbles cause blood clot's demise

Cornell engineers create smartCARD that uses smartphone's camera to read cholesterol level

Cornell engineers create smartCARD that uses smartphone's camera to read cholesterol level

Cancer cells that fuse with macrophages play key role in the spread of cancer

Cancer cells that fuse with macrophages play key role in the spread of cancer

Blending more ethanol into fuel to reduce air pollution carries hidden risk

Blending more ethanol into fuel to reduce air pollution carries hidden risk

Daily exercise lessens harmful physiological effects of short-term overeating, inactivity, says study

Daily exercise lessens harmful physiological effects of short-term overeating, inactivity, says study

Possible mechanism behind elevated risk of cardiovascular disease discovered in HIV-infected women

Possible mechanism behind elevated risk of cardiovascular disease discovered in HIV-infected women

Study: Brain blood vessel cells may be therapeutic targets for Alzheimer's disease

Study: Brain blood vessel cells may be therapeutic targets for Alzheimer's disease

New UCSF-led study links obesity to development of chronic kidney disease

New UCSF-led study links obesity to development of chronic kidney disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.